CSI Infection: Method used in hunt for serial killers turns to killer diseases

Every 30 seconds, infectious diseases such as malaria, HIV/AIDS and tuberculosis kill as many people as Jack the Ripper did in his entire career. New research published in BioMed Central's open access journal International Journal of Health Geographics demonstrates how the mathematical model of geographic profiling, used in the hunt for serial killers, can help combat infectious diseases.

A tried and tested method used in the hunt for serial killers can help combat infectious diseases, research from Queen Mary, University of London reveals.

Geographical profiling, a statistical technique which uses the locations of crimes to identify areas in which the serial criminal is most likely to live and work, was originally developed to help police prioritise suspects. It has been successfully used by law enforcement agencies around the world, including the Royal Canadian Mounted Police, Scotland Yard and the Bureau of Alcohol, Tobacco, Firearms and Explosives.

New research from Dr Steven Le Comber at Queen Mary’s School of Biological and Chemical Sciences has shown that this mathematical method can be used to map the locations of diseases to try and identify the source of the disease.

Dr Le Comber, in collaboration with scientists at the University of Miami and Ain Shams University in Cairo, as well as with the inventor of geographic profiling, former detective turned Professor of Criminal Justice Kim Rossmo from Texas State University, examined the 1854 cholera outbreak in London, and more recent cases of malaria in Cairo.

In both cases, geographic profiling successfully located the sources of the disease - the Broad Street pump in London, and the breeding habitats of the mosquito Anopheles sergentii in Cairo.

The findings were published in BioMed Central’s International Journal of Health Geographics today (18 May 2011).

“This is a very exciting development,” said Dr Le Comber.

“Correctly applied, geographic profiling shows great promise as a useful component of policy relating to the control of a wide variety of infectious diseases.

“Evidence-based targeting of interventions like this is more efficient, environmentally friendly and cost effective than untargeted intervention.”

More information: Geographic profiling as a novel spatial tool for targeting infectious disease control, Steven C Le Comber, D KIM Rossmo, Ali N Hassan, Doug O Fuller and John C Beier, International Journal of Health Geographics (in press)

add to favorites email to friend print save as pdf

Related Stories

The buzz of the chase

Jul 30, 2008

Scientists from Queen Mary, University of London are helping to perfect a technique used to catch serial killers, by testing it on bumblebees.

Recommended for you

Global impact of the Ebola outbreak

3 minutes ago

The Ebola virus has been spreading in West Africa since March, but the current outbreak over the past few weeks has reached new heights and elevated the crisis. More than 650 people have died, and in recent days it was learned ...

S.Korea detects second foot-and-mouth case

2 hours ago

South Korea on Monday reported its second case of foot-and-mouth disease in less than a week, triggering fearful memories of a devastating 2011 outbreak that forced the culling of millions of livestock.

Ebola kills Liberian doctor, 2 Americans infected

2 hours ago

(AP)—One of Liberia's most high-profile doctors has died of Ebola, officials said Sunday, and an American physician was being treated for the deadly virus, highlighting the risks facing health workers trying ...

Hepatitis C virus genotype 1 is most prevalent worldwide

3 hours ago

In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journa ...

1 in 3000 blood donors in England infected with hepatitis E

3 hours ago

The first systematic analysis of hepatitis E virus (HEV) transmission by blood components indicates that about 1 in 3000 donors in England have HEV in their plasma. The findings, published in The Lancet, suggest that around ...

Biologic treatments for RA carry similar infection risk

3 hours ago

(HealthDay)—The risk of hospitalized bacterial infections in older rheumatoid arthritis (RA) patients is similar for rituximab or abatacept compared to etanercept, although it is higher for infliximab, ...

User comments